AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $49,000 | -77.2% | 69,107 | -26.6% | 0.00% | – |
| Q4 2021 | $215,000 | +92.0% | 94,135 | +141.0% | 0.00% | – |
| Q3 2021 | $112,000 | -24.3% | 39,062 | 0.0% | 0.00% | – |
| Q2 2021 | $148,000 | +12.1% | 39,062 | 0.0% | 0.00% | – |
| Q1 2021 | $132,000 | -9.6% | 39,062 | -25.1% | 0.00% | – |
| Q4 2020 | $146,000 | -7.6% | 52,124 | -17.9% | 0.00% | – |
| Q3 2020 | $158,000 | -58.3% | 63,462 | +127.2% | 0.00% | -100.0% |
| Q2 2020 | $379,000 | +62.0% | 27,930 | -7.3% | 0.00% | 0.0% |
| Q1 2020 | $234,000 | +39.3% | 30,119 | +16.5% | 0.00% | – |
| Q4 2019 | $168,000 | -74.9% | 25,855 | -84.8% | 0.00% | -100.0% |
| Q3 2019 | $668,000 | – | 170,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |